STLR Link Roundup – March 5, 2019

High Court Limit On Costs In Copyright Cases Clarifies Stakes In a U.S. Supreme Court decision on March 4, 2019, the court ruled that “a federal district court’s discretion to award ‘full costs’ to a party in copyright litigation is limited to the six categories specified in the general costs statute.” In the case Rimini Street Inc. v. Oracle USA Inc., the District Court awarded Oracle fees and costs, including $12.8 million for litigation expenses Continue Reading →

The Future of Personalized Medicine: How Should Genomic Sequencing Be Regulated?

Background Healthcare is currently making a historic transition towards personalized medicine, a new and emerging healthcare model for treatment and prevention strategies tailored towards the client’s specific genetic variation, lifestyle, and environment. Among the tools used in this model, genomic sequencing is one that is quintessential to the creation and effectiveness of these strategic plans. Breakthroughs in science and technology allow laboratories to sequence an entire human genome within 24 hours and at a reasonably Continue Reading →